C-Reactive Protein (CRP) Test Market Size, Share & Trends Analysis Report By Assay Type, By Detection Range, By Disease Area (Cardiovascular Disease, Cancer, Rheumatoid Arthritis), By End Use, And Segment Forecasts, 2018 - 2025

Published: Mar, 2018 | Pages: 181 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global c-reactive protein (CRP) testing market size is expected to reach USD 1.77 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 1.3% during the forecast period. Rising incidence of inflammatory disorders such as cancer infections and cardiovascular disorders is one of the leading factors driving market growth. Furthermore, increasing global incidence of endometriosis in women is expected to play a major role in the CRP testing market over the forecast period.

Increase in funds provided to academic research institutions and individual researchers is expected to boost growth. Moreover, various initiatives by international bodies such as WHO and NIH for prevention and treatment of chronic disorders such as cardiovascular diseases and cancer are anticipated to promote growth.

Point-of-care devices for CRP testing are being increasingly adopted by healthcare professionals in clinics and hospitals. Technological advancements in these portable, rapid, and easy-to-use testing devices are expected to strengthen POC settings. Additionally, collaborations among governments, companies, and research institutions are expected to drive the growth of CRP diagnostic devices.

Further key findings from the report suggest:

• By type of assay, immunoturbidimetric assays are estimated to account for the largest revenue share owing to adequate availability of CRP testing kits based on this technology

• Based on disease type, cardiovascular disorders accounted for the largest market share owing to higher clinical significance of CRP levels in disease-oriented studies for cardiac infections and strokes

• On the basis of end use, clinics are estimated to account for the largest share in terms of revenue, owing to favorable government policies in the field of primary healthcare settings

• North America dominated the market due to presence of a well-established healthcare framework, government support, increase in investigational studies in this field, and presence of a substantial number of regional players

• Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to presence of local as well as international market players, extensive research, and favorable government support

• Major players include Thermo Fisher Scientific, Inc.; F Hoffmann-La Roche Ltd.;Ortho Clinical Diagnostics; Quest Diagnostics; Danaher; Siemens Healthineers; Abbott; Abaxis, Inc.; Merck & Co., Inc.; Laboratory Corporation of America Holdings; Getein Biotech, Inc.;Randox Laboratories Ltd.;BODITECH MED, INC.; Orion Diagnostica Oy; and HORIBA, Ltd.

• Companies are entering into collaborations with academic institutions and private and public entities to promote advancements in the space, which is ultimately driving the growth of the C-reactive protein testing market.

 Table of Contents

Chapter 1 Research Methodology
                 1.1 Information Procurement
                      1.1.1 Purchased database:
                      1.1.2 GVR's Internal Database
                 1.2 Data Analysis
                 1.3 Market Formulation & Validation

Chapter 2 Executive Summary
                 2.1 Market Snapshot

Chapter 3 C-Reactive Protein Testing Market Variables, Trends & Scope
                 3.1 Market Segmentation &Scope
                      3.1.1 Market driver analysis
                           3.1.1.1 High R&D in the field of C-reactive protein testing
                           3.1.1.2 Rising burden of inflammatory disorders
                      3.1.2 Market restraint analysis
                           3.1.2.1 Availability of alternative disease testing methods
                 3.2 Penetration & Growth Prospect Mapping for Methods, 2016
                 3.3 C-Reactive Protein Testing Market-SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
                 3.4 Industry Analysis - Porter's

Chapter 4 C-Reactive Protein Testing: Assay Type Estimates & Trend Analysis
                 4.1 Global C-reactive protein testing Market: Assay Type Movement Analysis
                 4.2 Immunoturbidimetric Assay
                      4.2.1 Global immunoturbidimetric assay market, 2014 - 2025 (USD Million)
                 4.3 ELISA
                      4.3.1 Global ELISA market, 2014 - 2025 (USD Million)
                      4.3.2 Clinical
                           4.3.2.1 Global clinical market, 2014 - 2025 (USD Million)
                      4.3.3 Non-Clinical
                           4.3.3.1 Global non-clinical market, 2014 - 2025 (USD Million)
                 4.4 Chemiluminescence Immunoassay (CLIA)
                      4.4.1 Global Chemiluminescence Immunoassay (CLIA) market, 2014 - 2025 (USD Million)
                 4.5 Others
                      4.5.1 Global others market, 2014 - 2025 (USD Million)

Chapter 5 C-Reactive Protein Testing: Detection Range Estimates & Trend Analysis
                 5.1 Global C-Reactive Protein Testing Market: Detection Range Movement Analysis
                 5.2 High sensitivity C-reactive protein
                      5.2.1 Global hsCRP market, 2014 - 2025 (USD Million)
                 5.3 Conventional CRP
                      5.3.1 Global conventional CRP market, 2014 - 2025 (USD Million)
                 5.4 Cardiac CRP (cCRP)
                      5.4.1 Global cardiac CRP market, 2014 - 2025 (USD Million)

Chapter 6 C-Reactive Protein Testing: Disease Area Estimates & Trend Analysis
                 6.1 Global C-reactive protein testing Market: Disease Area Movement Analysis
                 6.2 Cardiovascular diseases
                      6.2.1 Global cardiovascular diseases market, 2014 - 2025 (USD Million)
                 6.3 Cancer
                      6.3.1 Global cancer market, 2014 - 2025 (USD Million)
                 6.4 Rheumatoid Arthritis
                      6.4.1 Global rheumatoid arthritis market, 2014 - 2025 (USD Million)
                 6.5 Inflammatory bowel disease
                      6.5.1 Global inflammatory bowel disease market, 2014 - 2025 (USD Million)
                 6.6 Endometriosis
                      6.6.1 Global endometriosis market, 2014 - 2025 (USD Million)
                 6.7 Lupus
                      6.7.1 Global lupus market, 2014 - 2025 (USD Million)
                 6.8 Others
                      6.8.1 Global others market, 2014 - 2025 (USD Million)

Chapter 7 C-Reactive Protein Testing: End-Use Estimates & Trend Analysis
                 7.1 Global C-reactive protein testing Market: End-Use Movement Analysis
                 7.2 Clinics
                      7.2.1 Global clinics market, 2014 - 2025 (USD Million)
                 7.3 Hospitals
                      7.3.1 Global hospitals market, 2014 - 2025 (USD Million)
                 7.4 Laboratories
                      7.4.1 Global laboratories market, 2014 - 2025 (USD Million)
                 7.5 Assisted living healthcare facilities
                      7.5.1 Global assisted living healthcare facilities market, 2014 - 2025 (USD Million)
                 7.6 Home
                      7.6.1 Global home market, 2014 - 2025 (USD Million)
                 7.7 Others
                      7.7.1 Global others market, 2014 - 2025 (USD Million)

Chapter 8 C-Reactive Protein Testing: Regional Estimates & Trend Analysis by Assay Type, Detection Range, Disease Area, & End Use
                 8.1 C-reactive protein testing Market Share by Region, 2016 & 2025
                 8.2 North America
                      8.2.1 North America C-reactive protein testing market, 2014 - 2025 (USD Million)
                      8.2.2 U.S.
                           8.2.2.1 U.S. C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
                           8.2.2.2 U.S. C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
                           8.2.2.3 U.S. C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
                           8.2.2.4 U.S. C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
                      8.2.3 Canada
                           8.2.3.1 Canada C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
                           8.2.3.2 Canada C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
                           8.2.3.3 Canada C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
                           8.2.3.4 Canada C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
                 8.3 Europe
                      8.3.1 Europe C-reactive protein testing market, 2014 - 2025 (USD Million)
                      8.3.2 Germany
                           8.3.2.1 Germany C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
                           8.3.2.2 Germany C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
                           8.3.2.3 Germany C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
                           8.3.2.4 Germany C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
                      8.3.3 U.K.
                           8.3.3.1 U.K. C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
                           8.3.3.2 U.K. C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
                           8.3.3.3 U.K. C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
                           8.3.3.4 U.K. C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
                 8.4 Asia Pacific
                      8.4.1 Asia Pacific C-reactive protein testing market, 2014 - 2025 (USD Million)
                      8.4.2 Japan
                           8.4.2.1 Japan C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
                           8.4.2.2 Japan C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
                           8.4.2.3 Japan C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
                           8.4.2.4 Japan C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
                      8.4.3 China
                           8.4.3.1 China C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
                           8.4.3.2 China C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
                           8.4.3.3 China C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
                           8.4.3.4 China C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
                 8.5 Latin America
                      8.5.1 Latin America C-reactive protein testing market, 2014 - 2025 (USD Million)
                      8.5.2 Brazil
                           8.5.2.1 Brazil C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
                           8.5.2.2 Brazil C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
                           8.5.2.3 Brazil C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
                           8.5.2.4 Brazil C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
                 8.6 Middle East & Africa (MEA)
                      8.6.1 Middle East & Africa C-reactive protein testing market, 2014 - 2025 (USD Million)
                      8.6.2 South Africa
                           8.6.2.1 South Africa C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
                           8.6.2.2 South Africa C-reactive protein testing market, by detection range, 2014 - 2025 (USD Million)
                           8.6.2.3 South Africa C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
                           8.6.2.4 South Africa C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)

Chapter 9 Competitive Landscape
                 9.1 List of Companies
                 9.2 Market Participation Categorization
                 9.3 Company Profiles
                      9.3.1 Thermo Fisher Scientific, Inc.
                           9.3.1.1 Company overview
                           9.3.1.2 Financial performance
                           9.3.1.3 Product benchmarking
                           9.3.1.4 Strategic initiatives
                      9.3.2 Ortho Clinical Diagnostics
                           9.3.2.1 Company overview
                           9.3.2.2 Financial performance
                           9.3.2.3 Product benchmarking
                           9.3.2.4 Strategic initiatives
                      9.3.3 F Hoffmann-La Roche Ltd.
                           9.3.3.1 Company overview
                           9.3.3.2 Financial performance
                           9.3.3.3 Product benchmarking
                           9.3.3.4 Strategic initiatives
                      9.3.4 Danaher
                           9.3.4.1 Company overview
                                9.3.4.1.1 Beckman Coulter, Inc.
                           9.3.4.2 Financial performance
                           9.3.4.3 Product benchmarking
                           9.3.4.4 Strategic initiatives
                      9.3.5 Quest Diagnostics
                           9.3.5.1 Company overview
                           9.3.5.2 Financial performance
                           9.3.5.3 Product benchmarking
                           9.3.5.4 Strategic initiatives
                      9.3.6 Siemens Healthineers
                           9.3.6.1 Company overview
                           9.3.6.2 Financial performance
                           9.3.6.3 Product benchmarking
                           9.3.6.4 Strategic initiatives
                      9.3.7 Abbott
                           9.3.7.1 Company overview
                                9.3.7.1.1 Alere Inc.
                           9.3.7.2 Financial performance
                           9.3.7.3 Product benchmarking
                           9.3.7.4 Strategic initiatives
                      9.3.8 Abaxis, Inc.
                           9.3.8.1 Company overview
                           9.3.8.2 Financial performance
                           9.3.8.3 Product benchmarking
                           9.3.8.4 Strategic initiatives
                      9.3.9 Merck & Co., Inc.
                           9.3.9.1 Company overview
                                9.3.9.1.1 Sigma-Aldrich Co. LLC
                           9.3.9.2 Financial performance
                           9.3.9.3 Product benchmarking
                           9.3.9.4 Strategic initiatives
                      9.3.10 LabCorp
                           9.3.10.1 Company overview
                           9.3.10.2 Financial performance
                           9.3.10.3 Product benchmarking
                           9.3.10.4 Strategic initiatives
                      9.3.11 Getein Biotech, Inc.
                           9.3.11.1 Company overview
                           9.3.11.2 Financial performance
                           9.3.11.3 Product benchmarking
                           9.3.11.4 Strategic initiatives
                      9.3.12 HORIBA Ltd.
                           9.3.12.1 Company overview
                           9.3.12.2 Financial performance
                           9.3.12.3 Product benchmarking
                           9.3.12.4 Strategic initiatives
                      9.3.13 Randox Laboratories Ltd.
                           9.3.13.1 Company overview
                           9.3.13.2 Financial performance
                           9.3.13.3 Product benchmarking
                           9.3.13.4 Strategic initiatives
                      9.3.14 BODITECH MED, INC.
                           9.3.14.1 Company overview
                           9.3.14.2 Financial performance
                           9.3.14.3 Product benchmarking
                           9.3.14.4 Strategic initiatives
                      9.3.15 Orion Diagnostica Oy
                           9.3.15.1 Company overview
                           9.3.15.2 Financial performance
                           9.3.15.3 Product benchmarking
                           9.3.15.4 Strategic initiatives

List of Tables

TABLE 1 Chances of heart diseases associated with CRP levels in blood
TABLE 2 Estimated new female cases of breast cancer & deaths in US, 2017
TABLE 3 North America C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 4 North America C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 5 North America C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 6 North America C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 7 North America C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 8 U.S. C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 9 U.S. C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 10 U.S. C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 11 U.S. C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 12 U.S. C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 13 Canada C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 14 Canada C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 15 Canada C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 16 Canada C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 17 Canada C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 18 Europe C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 19 Europe C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 20 Europe C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 21 Europe C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 22 Europe C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 23 Germany C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 24 Germany C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 25 Germany C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 26 Germany C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 27 Germany C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 28 U.K. C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 29 U.K. C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 30 U.K. C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 31 U.K. C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 32 U.K. C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 33 Asia Pacific C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 34 Asia Pacific C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 35 Asia Pacific C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 36 Asia Pacific C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 37 Asia Pacific C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 38 Japan C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 39 Japan C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 40 Japan C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 41 Japan C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 42 Japan C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 43 China C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 44 China C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 45 China C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 46 China C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 47 China C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 48 Latin America C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 49 Latin America C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 50 Latin America C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 51 Latin America C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 52 Latin America C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 53 Brazil C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 54 Brazil C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 55 Brazil C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 56 Brazil C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 57 Brazil C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 58 MEA C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 59 MEA C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 60 MEA C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 61 MEA C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 62 MEA C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)
TABLE 63 South Africa C-reactive protein testing market, by assay type, 2014 - 2025 (USD Million)
TABLE 64 South Africa C-reactive protein testing market, by ELISA 2014 - 2025 (USD Million)
TABLE 65 South Africa C-reactive protein testing market, by detection range 2014 - 2025 (USD Million)
TABLE 66 South Africa C-reactive protein testing market, by disease area, 2014 - 2025 (USD Million)
TABLE 67 South Africa C-reactive protein testing market, by end use, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for methods, 2016
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Global C-reactive protein testing market: Assay type outlook key takeaways
FIG. 16 Global C-reactive protein testing market: Assay type movement analysis
FIG. 17 Global immunoturbidimetric assay market, 2014 - 2025 (USD Million)
FIG. 18 Global ELISA market, 2014 - 2025 (USD Million)
FIG. 19 Global clinical market, 2014 - 2025 (USD Million)
FIG. 20 Global non-clinical market, 2014 - 2025 (USD Million)
FIG. 21 Global CLIA market, 2014 - 2025 (USD Million)
FIG. 22 Global others market, 2014 - 2025 (USD Million)
FIG. 23 Global C-reactive protein testing market: Detection range estimates outlook key takeaways
FIG. 24 Global C-reactive protein testing market: Detection range movement analysis
FIG. 25 Global hs-CRP market, 2014 - 2025 (USD Million)
FIG. 26 Global conventional CRP market, 2014 - 2025 (USD Million)
FIG. 27 Global cardiac CRP market, 2014 - 2025 (USD Million)
FIG. 28 Global C-reactive protein testing market: Disease area estimates outlook key takeaways
FIG. 29 Global C-reactive protein testing market: Disease Area movement analysis
FIG. 30 Global cardiovascular diseases market, 2014 - 2025 (USD Million)
FIG. 31 Global cancer market, 2014 - 2025 (USD Million)
FIG. 32 Global rheumatoid arthritis market, 2014 - 2025 (USD Million)
FIG. 33 Global inflammatory bowel disease market, 2014 - 2025 (USD Million)
FIG. 34 Global endometriosis market, 2014 - 2025 (USD Million)
FIG. 35 Global lupus market, 2014 - 2025 (USD Million)
FIG. 36 Global others market, 2014 - 2025 (USD Million)
FIG. 37 Global C-reactive protein testing market: End use estimates outlook key takeaways
FIG. 38 Global C-reactive protein testing market: End use movement analysis
FIG. 39 Global clinics market, 2014 - 2025 (USD Million)
FIG. 40 Global hospitals market, 2014 - 2025 (USD Million)
FIG. 41 Global laboratories market, 2014 - 2025 (USD Million)
FIG. 42 Global assisted living healthcare facilities market, 2014 - 2025 (USD Million)
FIG. 43 Global home market, 2014 - 2025 (USD Million)
FIG. 44 Global others market, 2014 - 2025 (USD Million)
FIG. 45 Regional market place: Key takeaway
FIG. 46 Global C-reactive protein testing market regional outlook, 2016 & 2025
FIG. 47 North America C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 48 CANADA C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 49 Canada C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 50 Europe C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 51 Germany C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 52 U.K. C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 53 Asia Pacific C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 54 Japan C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 55 China C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 56 Latin America C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 57 Brazil C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 58 Middle East & Africa C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 59 South Africa C-reactive protein testing market, 2014 - 2025 (USD Million)
FIG. 60 List of Companies
FIG. 61 Strategy framework
FIG. 62 Participant categorization